4-Difluoromethoxy-2-ethylbenzooxazole-7-carboxylic acid → 4-Difluoromethoxy-2-ethylbenzooxazole-7-carboxylic acid (2-ethyl-4-methyl-2H-pyrazol-3-yl)-amide
Reaction equation
[F:1][CH:2]([F:18])[O:3][C:4]1[C:9]2[N:10]=[C:11]([CH2:13][CH3:14])[O:12][C:8]=2[C:7]([C:15]([OH:17])=O)=[CH:6][CH:5]=1.[CH2:19]([N:21]1[C:25]([NH2:26])=[C:24]([CH3:27])[CH:23]=[N:22]1)[CH3:20]>>[CH2:19]([N:21]1[C:25]([NH:26][C:15]([C:7]2[C:8]3[O:12][C:11]([CH2:13][CH3:14])=[N:10][C:9]=3[C:4]([O:3][CH:2]([F:1])[F:18])=[CH:5][CH:6]=2)=[O:17])=[C:24]([CH3:27])[CH:23]=[N:22]1)[CH3:20]Participants
3
Procedure
Starting from 4-difluoromethoxy-2-ethylbenzooxazole-7-carboxylic acid (150 mg) and 2-ethyl-4-methyl-2H-pyrazol-3-ylamine (90 mg). Purification by column chromatography on silica eluting 2:1 ethyl acetate-heptane followed by ethyl acetate afforded the title compound as a white solid (85 mg).
Workup
- customPurification by column chromatography on silica eluting 2:1 ethyl acetate-heptane
Sources & evidence
- ORD record
- ord-21921eee26c14d179d3557a468f415d1
- Source dataset
- uspto-grants-2002_06
- Patent number
- US06403791B1
Reaction notes
Loading…